-transparent.png){kind=logo}
Male CD-1 mice in groups of 52, 53 or 100 were administered piperonyl butoxide (alpha-[2-(2-butoxyethoxy)ethoxy-4,5-methylenedioxy-2-propyltol uene) in the diet at levels of 0 (control), 0.6 and 1.2% for 12 months. Hepatocellular carcinoma was induced in treated groups in a dose-dependent manner but not in the control group. The incidences of hepatocellular carcinoma were 11.3 and 52.0% in mice given 0.6 and 1.2% piperonyl butoxide, indicating that piperonyl butoxide can cause hepatocellular carcinoma in mice as it is known to do in rats.
Related Publications
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
August 1993,
Toxicology letters,
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
September 2022,
Reproductive toxicology (Elmsford, N.Y.),
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
January 1983,
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans,
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
November 1993,
Toxicology,
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
October 1993,
Toxicology,
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
July 1997,
Fundamental and applied toxicology : official journal of the Society of Toxicology,
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
January 1992,
Toxicology letters,
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
October 2009,
Toxicologic pathology,
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
June 1998,
Human & experimental toxicology,
O Takahashi, and
S Oishi, and
T Fujitani, and
T Tanaka, and
M Yoneyama
October 1984,
Epilepsia,
